These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8291573)

  • 1. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.
    Kurth MC; Kurth JH
    Am J Med Genet; 1993 Oct; 48(3):166-8. PubMed ID: 8291573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the oxidative polymorphism and early onset of Parkinson's disease.
    Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
    Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
    Tao E; Liu Z; Chen B; Pan X; Shao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis.
    Christensen PM; Gøtzsche PC; Brøsen K
    Pharmacogenetics; 1998 Dec; 8(6):473-9. PubMed ID: 9918130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
    Liu P; Liu Z; Shao M; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 9. P450 enzymes and Parkinson's disease: the story so far.
    Riedl AG; Watts PM; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease.
    Pang CP; Zhang J; Woo J; Chan D; Law LK; Tong SF; Kwok T; Kay R
    Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.
    Vilar R; Coelho H; Rodrigues E; Gama MJ; Rivera I; Taioli E; Lechner MC
    Eur J Neurol; 2007 Feb; 14(2):156-61. PubMed ID: 17250723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
    Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD15 variants in patients with sporadic Parkinson's disease.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
    Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families.
    Lucotte G; Turpin JC; Gérard N; Panserat S; Krishnamoorthy R
    Am J Med Genet; 1996 Jul; 67(4):361-5. PubMed ID: 8837703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association between the tau gene A0/A0 genotype and Parkinson's disease.
    Pastor P; Ezquerra M; Muñoz E; Martí MJ; Blesa R; Tolosa E; Oliva R
    Ann Neurol; 2000 Feb; 47(2):242-5. PubMed ID: 10665497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
    Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC
    Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver enzyme abnormalities in Parkinson's disease.
    Tanner CM
    Geriatrics; 1991 Aug; 46 Suppl 1():60-3. PubMed ID: 1894148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debrisoquine hydroxylase and Parkinson's disease.
    Kondo I; Kanazawa I
    Adv Neurol; 1993; 60():338-42. PubMed ID: 8420147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.